Calidi Biotherapeutics, Inc.
Calidi Biotherapeutics Reports Third Quarter 2026 Financial Results and Recent Business Highlights
- Continued to advance the development of CLD-401 towards the clinic
Company newsroom
Calidi Biotherapeutics, Inc.
NYSE AMERICAN:CLDI
1 releases